PHENAZOPYRIDINE HCL

Phenazopyridine HCl is a urinary analgesic that exerts a local anesthetic effect on the mucosa of the urinary tract, helping relieve pain, burning, urgency, and discomfort associated with irritation or infection. Side effects may include orange or red urine discoloration, headache, stomach upset, and, rarely, hemolytic anemia or methemoglobinemia, particularly in patients with renal impairment or prolonged use beyond recommended duration. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 426984cd4dbc Category: Tag:

Product Description


Mechanism of Action

PHENAZOPYRIDINE HCL demonstrates a multidimensional biochemical activity pattern, affecting enzymeregulated catalytic networks, receptormediated intracellular signalling, mitochondrial respiratory pathways, oxidativestress regulation, ionchannel behaviour, cytoskeletal mechanics and transcriptionfactor network modulation. Structural evidence suggests potential interactions with catalytic residues, allosteric domains, transmembrane protein complexes, regulatory scaffolds and intracellular signalling intermediates. These interactions allow PHENAZOPYRIDINE HCL to influence phosphorylation kinetics, secondmessenger signalling (Ca²⁺, cAMP, IP, DAG), redoxbuffering systems, ATP turnover rates and mitochondrial membranepotential stability.

Depending on experimental conditions, PHENAZOPYRIDINE HCL may alter metabolic flux distribution, cytoskeletal tension, vesicular transport efficiency, chromatinaccessibility patterns and geneexpression networks related to stress responses, inflammation, apoptosis, autophagy and metabolic adaptation.

Benefits and Advantages

This compound is widely used across highresolution biochemical and pharmacological research areas, including:

  • Receptorligand interaction analysis and affinitymapping
  • Detailed enzymekinetics profiling and catalyticpathway evaluation
  • Mitochondrialdynamics studies, ATPflux modelling and oxidativestress research
  • Integrated multiomics applications (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membranemechanics modelling
  • Apoptosis, necroptosis, ferroptosis and autophagy signalling pathway studies
  • SAR (structureactivity relationship) and molecularoptimisation pipelines
  • Mechanistic pharmacodynamic modelling and thresholdactivation experiments

Side Effects and Risks

Laboratoryobserved risks include:

  • Oxidativestress imbalance and ROS overproduction
  • Mitochondrial overload or suppression of respiratorychain complexes
  • Dysregulation of Na⁺/K⁺/Ca²⁺ transport and ionchannel behaviour
  • Unintended receptor crosstalk or inhibitory interference
  • Cytoskeletal destabilisation and membrane-integrity compromise
  • Dosedependent cytotoxicity leading to apoptosis or autophagy
  • Transcriptional instability or inflammatory signalling activation (NF-κB, JNK, MAPK)

Use exclusively under controlled laboratory conditions with strict biosafety procedures.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C11H11N5·HCl

Molecular Weight

249.70 g/mol

CAS Number

136-40-3

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

30.4 [ug/mL] (The mean of the results at pH 7.4)

Purity

Purity information is available upon request (COA).

Synonym

Phenazopyridine hydrochloride; 136-40-3; Phenazopyridine HCl; Pyridium; Urodine

IUPAC/Chemical Name

3-phenyldiazenylpyridine-2,6-diamine;hydrochloride

InChl Key

QQBPIHBUCMDKFG-UHFFFAOYSA-N

InChl Code

InChI=1S/C11H11N5.ClH/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8;/h1-7H,(H4,12,13,14);1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/8691;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download